Opdivo Use For Urothelial Cancer Blocked By NICE In Draft Guidance

 
• By Lucie Ellis-Taitt
  
Benefit & Cost
NICE not convinced Opdivo's benefits outweigh its costs
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip